Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Vascular endothelial growth factor and endoglin expression in colorectal cancer
Journal of Cancer Research & Clinical Oncology, 11/11/09
Dassoulas K et al. – Our results support that VEGF and endoglin act as two valuable indicators of prognosis
Methods- VEGF and endoglin expression evaluated in 99 unrelated patients with colorectal cancer using immunohistochemistry
- Vascular endothelial growth factor and endoglobin expression positively interrelated
- No significant correlation of VEGF and endoglin expression with clinicopathological parameters observed in our cases
- Kaplan–Meier survival curves demonstrated a clear association of cancer-specific overall survival with high VEGF, as well as high endoglin expression
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes
Journal of Cancer Research & Clinical Oncology, 03/16/10
Targeting HOX and PBX transcription factors in ovarian cancer
BMC Cancer, 03/16/10
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
Annals of Oncology, 03/16/10
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
Annals of Oncology, 03/16/10
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
Annals of Oncology, 03/16/10
Article Search
Sponsor
Sponsor


See Latest Articles


